These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7768120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Current status of hormonotherapy of metastatic cancer of the breast].
    Namer M.
    Bull Cancer; 1989; 76(1):65-73. PubMed ID: 2713517
    [Abstract] [Full Text] [Related]

  • 3. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS, El-Hajj II, Makarem JA, Otrock ZK.
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ.
    Oncologist; 1998 Sep; 3(2):129-130. PubMed ID: 10388095
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A.
    J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148
    [Abstract] [Full Text] [Related]

  • 8. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M.
    Cancer Res; 1999 Aug 01; 59(15):3646-51. PubMed ID: 10446976
    [Abstract] [Full Text] [Related]

  • 9. [The use of GnRH analogues in early and advanced breast carcinomas].
    Ségura C, Avenin D, Gligorov J, Selle F, Estéso A, Beerblock K, Emile G, Do Huyen N, Lotz JP.
    Gynecol Obstet Fertil; 2005 Nov 01; 33(11):914-9. PubMed ID: 16246613
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endocrine therapy for early breast cancer.
    Hussain SA, Williams S, Stevens A, Rea DW.
    Expert Rev Anticancer Ther; 2004 Oct 01; 4(5):877-88. PubMed ID: 15485321
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of endocrine therapy.
    Pritchard KI, Sutherland DJ.
    Hematol Oncol Clin North Am; 1989 Dec 01; 3(4):765-805. PubMed ID: 2481670
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Brown RJ, Davidson NE.
    Semin Oncol; 2006 Dec 01; 33(6):657-63. PubMed ID: 17145345
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE.
    Cancer; 2004 Sep 15; 101(6):1311-22. PubMed ID: 15368322
    [Abstract] [Full Text] [Related]

  • 20. [Aromatase inhibitors in the adjuvant therapy of breast cancer].
    Bauerschlag D, Schem C, Maass N, Jonat W.
    Gynakol Geburtshilfliche Rundsch; 2005 Jun 15; 45(3):132-6. PubMed ID: 15990437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.